Compare AU
Compare VAF vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Australian Fixed Interest Index ETF (VAF) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
VAF | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 181 | 63 |
Median incremental investment | $1,018.39 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,487.24 | $1,905.75 |
Average age group | > 35 | 26 - 35 |
Key Summary
VAF | DRUG | |
|---|---|---|
Strategy | VAF.AX was created on 2012-10-29 by Vanguard. The fund's investment portfolio concentrates primarily on investment grade fixed income. Vanguard Australian Fixed Interest Index ETF seeks to track the return of the Bloomberg AusBond Composite 0+ Yr Index before taking into account fees, expenses and tax. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Australia Government Bond 4.25 2026-04-21 (2.95 %) Australia Government Bond 3.25 2025-04-21 (2.84 %) Australia Government Bond 0.25 2024-11-21 (2.73 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.1 % | 0.57 % |
Key Summary
VAF | DRUG | |
|---|---|---|
Issuer | Vanguard | BetaShares |
Tracking index | Bloomberg AusBond Composite 0+ Yr Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.1 % | 0.57 % |
Price | $46.06 | $8.25 |
Size | $6.774 million | $182.401 million |
10Y return | -8.05 % | N/A |
Annual distribution yield (5Y) | 2.14 % | 1.90 % |
Market | ASX | ASX |
First listed date | 31/10/2012 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VAF | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 181 | 63 |
Median incremental investment | $1,018.39 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,487.24 | $1,905.75 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
VAF | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
VAF | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |